December 7, 2022 —  While heart disease is a leading cause of death in the United States, most people can be treated with early detection and timely interventions. That’s why Zheng Yan and a team of researchers at the University of Missouri are using a $2.6 million grant from the National Institutes of Health (NIH) to help create a breathable material — with antibacterial and antiviral properties — to support the team’s ongoing development of a multifunctional, wearable heart monitor. 

December 7, 2022 —  Compared with team-based care alone, the addition of a computerized clinical decision support system (CDSS) significantly reduced cardiovascular risk factors in patients with diabetes. These findings may have important public health and clinical significance in low- and middle-income countries where there is a lack of diabetes specialists to manage patients. The findings are published in Annals of Internal Medicine. 

December 7, 2022 —   BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today anno

December 7, 2022 — Ultromics has announced that its EchoGo Heart Failure, an artificial intelligence (AI) platform for echocardiography, with the potential to revolutionize the diagnosis of heart failure with preserved ejection fraction (HFpEF), has received US Food and Drug Administration (FDA) clearance.

ACC Cardiovascular Summit 2023

ICE2023 Imaging Conference and Expo

December 5, 2022 —  The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices, including limited supplies of IAB catheters, new Cardiosave IABPs, and Cardiosave IABP parts. 

Recommendations 

The FDA recommends that health care facilities and providers who use Getinge Maquet/Datascope IAB catheters or IABP devices: 

Nuclear Cardiology Today

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now